Ignite Creation Date:
2024-05-05 @ 4:44 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00302016
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2011-08-26
First Post:
2006-03-09
Brief Title:
Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis